drugset / Trial / NCT06761898

A Study of Different Forms of BGB-43395 and Food Effect in Healthy Participants

NCT06761898

Phase 1 Completed 51 enrolled BeiGene
RandomizedCrossoverOpen-labelTreatment

Summary

Study to determine the relative bioavailability of BGB-43395 solid dispersion tablet compared to salt tablet in healthy adult participants in Part 1 and the effect of food on the selected BGB-43395 formulation solid dispersion tablet or salt tablet in healthy adult participants in Part 2.

Timeline

Start
2025-01-14
Primary completion
2025-05-20
Completion
2025-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject BGB-43395 Unknown Oral

Indications

No indication recorded.